A Study of NBL-028 in Patients With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

270

Participants

Timeline

Start Date

March 8, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions

Advanced Solid Tumor

Interventions

DRUG

NBL-028

Intravenous infusion (IV), once every two weeks (one treatment cycle is 4 weeks).

Trial Locations (1)

RECRUITING

No.896 East Zhongshan Road, Shijiazhuang, Hebei Province, China., Shijiazhuang